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Abstract
Influenza viruses replicate within the nucleus of infected cells. Viral genomic RNA, three
polymerase subunits (PB2, PB1, and PA), and the nucleoprotein (NP) form ribonucleoprotein
complexes (RNPs) that are exported from the nucleus late during the infectious cycle. The virus-
induced Raf/MEK/ERK (MAPK) signal cascade is crucial for efficient virus replication. Blockade of
this pathway retards RNP export and reduces virus titers. Hemagglutinin (HA) accumulation and
its tight association with lipid rafts activate ERK and enhance localization of cytoplasmic RNPs. We
studied the induction of MAPK signal cascade by two seasonal human influenza A viruses A/HK/
218449/06 (H3N2) and A/HK/218847/06 (H1N1) that differed substantially in their replication
efficiency in tissue culture. Infection with H3N2 virus, which replicates efficiently, resulted in higher
HA expression and its accumulation on the cell membrane, leading to substantially increased
activation of MAPK signaling compared to that caused by H1N1 subtype. More H3N2-HAs were
expressed and accumulated on the cell membrane than did H1N1-HAs. Viral polymerase genes,
particularly H3N2-PB1 and H3N2-PB2, were observed to contribute to increased viral polymerase
activity. Applying plasmid-based reverse genetics to analyze the role of PB1 protein in activating
HA-induced MAPK cascade showed that recombinant H1N1 virus possessing the H3N2-PB1
(rgH1N1/H3N2-PB1) induced greater ERK activation, resulting in increased nuclear export of the
viral genome and higr virus titers. We conclude that enhanced viral polymerase activity promotes
the replication and transcription of viral RNA leading to increased accumulation of HA on the cell
surface and thereby resulting in an upregulation of the MAPK cascade and more efficient nuclear
RNP-export as well as virus production.
Background
Influenza viruses are members of the Orthomyxoviridae
family of RNA viruses and are grouped into types A, B, and
C on the basis of their nucleoprotein (NP) and matrix pro-
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tein characteristics. Type A influenza viruses (IVAs) are
classified into subtypes based on two proteins on the sur-
face of the virus, hemagglutinin (HA) and neuraminidase
(NA). IVAs infect a large variety of mammals and birds,
occasionally producing devastating pandemics in humans
[1]. Epidemics frequently occur between pandemics as a
result of gradual antigenic change in the prevalent virus;
this phenomenon is termed antigenic drift [2]. Currently,
human influenza epidemics are caused by H1N1 and
H3N2 IVAs or by type B influenza viruses (IVBs) [1,3].
Three notable (1918, 1958 and 1968) severe pandemics
have occurred during the 20th century: An H1N1 IVA
caused the 1918 "Spanish flu" pandemic, while an H3N2
IVA was responsible for the 1968 "Hong Kong flu" pan-
demic [4,5]. Since the appearance of H3N2 in 1968 and
the reappearance of H1N1 in 1977, IVAs have continued
to circulate in humans. Although infection with either of
these strains appears to have similar clinical manifesta-
tions in humans and other mammals (e.g., swine), many
reports suggest that influenza caused by H3N2 viruses is
usually more severe than that caused by H1N1 subtype
[6].
The IVA genomes consist of eight single-stranded RNA
segments of negative polarity that encode up to 11 pro-
teins [7,8]. These RNA segments are associated with the
NP and the RNA-dependent RNA polymerase, which
comprises three polymerase subunits (PB1, PB2, and PA)
to form viral ribonucleoprotein complexes (RNPs), repre-
senting the minimal set of infectious viral structures.
Influenza viruses pursue a nuclear-replication strategy;
thus, the RNPs must be exported from the nucleus to the
cytoplasm to be enveloped with other viral proteins at the
cell membrane [7,8].
The cellular response to growth factors, inflammatory
cytokines, and other mitogens is often mediated by recep-
tors that are either G protein-linked or intrinsic protein
tyrosine kinases [9]. The binding of ligand to receptor
transmits a signal to one or more cascades of serine/thre-
onine kinases that utilize sequential phosphorylation to
transmit and amplify the signal [10-13]. These kinase cas-
cades are collectively known as mitogen-activated protein
kinase (MAPK) signaling cascades [11,14]. The Raf/MEK/
ERK pathway represents one of the best-characterized
MAPK signaling pathways. MAPK cascades are key regula-
tors of cellular responses such as proliferation, differenti-
ation, and apoptosis [15]. Many negative-strand RNA
viruses induce cellular signaling through MAPK cascades
[16-18]. Infection with IVAs or IVBs upregulates the Raf/
MEK/ERK cascade to support virus replication within the
infected host cells [19-22]. This signal cascade, which is
activated late during influenza infection, is essential for
efficient export of nuclear RNPs. MEK inhibition has been
shown to impair the nuclear RNP export and reduces virus
yields [23].
Recently, we demonstrated that HA accumulation at the
cell membrane and its tight association with lipid-raft
domains trigger virus-induced ERK activation [24], show-
ing an important role of HA as a viral inducer of MAPK
signaling. Although HA appears to be important, we can-
not exclude the involvement of other viral proteins or
processes in activating MAPK signaling. In this study, we
examined the activation levels of MAPK signaling induced
by two currently circulating human strains: A/Hong Kong/
218847/06 (H1N1) and A/Hong Kong/218449/06
(H3N2). These viruses were isolated from two different
patients in Hong Kong in 2006. We observed that the
H3N2 strain replicates more efficiently in tissue culture
than does the H1N1 and also induced higher levels of ERK
phosphorylation. The purpose of this study was to inves-
tigate whether higher viral replication efficiency is func-
tionally connected to stronger virus-induced MAPK
activation leading to enhanced nuclear RNP export and to
analyze the possible contribution of viral polymerase pro-
teins to HA-induced ERK activation.
Results
Human influenza virus A/HK/218449/06 (H3N2) replicates 
faster than A/HK/218847/06 (H1N1)
We characterized H1N1 and H3N2 IVAs isolated from
two patients in Hong Kong in 2006. MDCK cells were
infected with either virus to determine the TCID50, viral
growth, and the level of viral protein synthesized during
infection. Logarithmic differences of viral infectivity titers
were determined 3 days after infection via serial dilution.
Infection with the H3N2 virus resulted in 2 log higher
TCID50/ml than that seen with the H1N1 infection, which
indicated higher production of infectious progeny virions
of the H3N2 subtype. To determine the viral growth curve,
we infected MDCK cells with either virus at m.o.i. = 2.
New infectious progeny virions of H3N2 IVA were
released within 4 h after infection, whereas almost no
H1N1 virus could be detected within this time frame. Fur-
thermore, a clear, at least 1 log increase in virus titers was
observed in H3N2-infected cells between 6 to 12 h post
infection (p.i.) (Fig. 1A). Additionally, a standard plaque
assay was used to analyze plaque morphology of MDCK
cells infected at m.o.i. = 1 after 3 days of incubation. The
H3N2 virus formed predominantly larger plaques (diam-
eter, 2.85 ± 0.71 mm) than that produced by the H1N1
(diameter, 1.22 ± 0.53 mm) (Fig. 1B) showing that the
H3N2 subtype possesses the capability to spread faster.
To evaluate whether the amount of viral proteins synthe-
sized during infection differed between these two strains,
we measured NP production at different times in MDCK
cells infected at m.o.i. = 1. Flow cytometry analysisVirology Journal 2007, 4:134 http://www.virologyj.com/content/4/1/134
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Growth properties of A/HK/218847/06 (H1N1) and A/HK/218449/06 (H3N2) influenza viruses Figure 1
Growth properties of A/HK/218847/06 (H1N1) and A/HK/218449/06 (H3N2) influenza viruses. (A) MDCK cells 
were infected with either H1N1 virus (blue line) or H2N3 virus (red line) at m.o.i. = 2. The growth curve is based on virus tit-
ers at the indicated time points after infection. The mean virus titers are given as log10 plaque forming units/ml. The error bars 
were derived from three independent experiments. (B) Plaque formation after virus titration on MDCK cells. The virus-con-
taining supernatant from cells infected at m.o.i. = 1 was harvested 9 h after infection. (C) MDCK cells were infected with either 
virus at m.o.i. = 1. The percentage of NP-expressing cells was measured by flow cytometry (FACS) using anti-NP mAb. The 
error bars were derived from three independent experiments.Virology Journal 2007, 4:134 http://www.virologyj.com/content/4/1/134
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revealed that the H3N2 IVA produced markedly more NP
than did the H1N1 at 4, 6, and 8 h p.i. (Fig. 1C). Whole-
cell populations infected with H1N1 showed 14% of the
cells were NP-expressing; at 4 h p.i., whereas 42% of the
whole-cell populations in the H3N2-infected cells were
NP+. Around 40% more viral NP was found in H3N2-
infected cells at 6 h p.i. and almost all of the cells were
infected by H3N2 at 8 h p.i. This finding showed optimal
replication of newly formed progeny virions of the H3N2
subtype. The amount of NP+ cells at 8 h after H1N1 infec-
tion was lower than that at 6 h after infection with H3N2.
Overall, our results clearly showed that the studied H3N2
virus possesses better growth capacity and replicates more
efficiently in tissue culture model than does the H1N1
subtype.
Infection with A/HK/218449/06 (H3N2) influenza virus 
induces stronger ERK phosphorylation and increased 
nuclear RNP export
Induction of MAPK signaling is essential for influenza
virus RNP export [23]. As the H3N2 and H1N1 viruses dif-
fered substantially in their replication efficiency in tissue
culture, we further examine the levels of MAPK induction
and concomitantly nuclear RNP export. MDCK cells
infected (m.o.i. = 1) with either type of virus were ana-
lyzed for ERK phosphorylation (activation) at different
time points p.i.. The virus-induced ERK activation found
in H3N2-infected cells was significantly stronger than that
in H1N1-infected cells at late time points after infection
(6 h and 8 h p.i.) (Fig. 2A). A reduction of H1N1-induced
ERK activation was observed at 8 h p.i., a time point when
ERK activation usually increases, as seen in cells infected
with H3N2 (Fig. 2A).
To investigate the Raf/MEK/ERK signaling-dependent
nuclear RNP export, we analyzed intracellular RNP locali-
zation in cells infected with either virus. In accordance
with flow cytometry analysis showing a very low amount
of viral NP produced by H1N1 virus at 4 h p.i., no H1N1-
NP was detected at this time point by confocal laser scan-
ning microscopy. RNPs were localized in the cytoplasm in
nearly all H3N2-infected cells at 6 and 8 h p.i., whereas in
H1N1-infected cells they were localized predominantly in
the nucleus or at the nuclear membrane at those time
points (Fig. 3). Consequently, the H3N2 virus titers were
approximately 90% higher than that of H1N1 (Fig. 2B).
These results suggest an association between efficient rep-
lication and higher levels of ERK activation. The less
induction of ERK activation by the H1N1 virus likely con-
tributed to the inefficient nuclear RNP export and lower
virus titers.
Replication and growth of both influenza strains depends 
on their ability to activate Raf/MEK/ERK signaling
The Raf/MEK/ERK signal cascade can be activated by
either protein kinase C alpha (PKCα)-dependent or Ras-
dependent pathways [24]. Upon their activation, both sig-
nal transmitters mediate phosphorylation of the kinase
Raf, which further activates ERK via MEK. Thereafter,
phosphorylated ERK translocates to the nucleus to phos-
phorylate a variety of substrates [11,12,14]. To verify if the
observed difference in ERK activation between H3N2 and
H1N1 viruses indeed involved MAPK signaling, we artifi-
cially enhanced or reduced the activation of MAPK signal-
ing by applying TPA, which is a strong PKC activator and
the specific MEK inhibitor U0126, respectively. In H1N1-
infected cells (m.o.i. = 1), TPA markedly enhanced ERK
activation at 6 h and 8 h p.i. (Fig. 4A), as well as cytoplas-
mic RNP localization at both time points (Fig. 5). Conse-
quently, the virus titers increased nearly 80% (Fig. 4B).
Because very little viral NP was synthesized during the first
4 h of H1N1 infection, no effect of TPA on nuclear RNP
export could be seen during that time.
We also assessed the effect of blocking ERK activity on
H3N2-infected cells. The levels of ERK phosphorylation in
H3N2-infected cells dramatically decreased (Fig. 4A). As a
result, the nucleocytoplasmic transport of viral RNPs out
of the nucleus during late infection was strongly sup-
pressed (Fig. 6) and virus titers were reduced by approxi-
mately 90% (Fig. 4B). These results further support that
the difference in the replication efficiency of the H1N1
and H3N2 viruses used in this study is caused on their
ability to induce ERK activation.
H3N2 influenza virus expresses more HA protein, which 
accumulates on the cell surface
We recently showed that membrane accumulation of the
HA protein triggers the activation of MAPK signaling [24].
In this study, we therefore analyzed the expression of HA
on the surface of MDCK cells infected with either virus
(m.o.i. = 1). The HA surface expression was measured at
different time points late during virus replication. To
ensure that the anti-HA antibody bound only to the HA
protein on the cell surface and not to cytoplasmic HA,
cells were fixed but not permeabilized. Flow cytometry
(FACS) analysis showed a substantial difference in the
amount of HA that accumulated on the cell membranes at
6 h and 8 h p.i.. 40% and 80% more membrane exposed
HA was found on H3N2-infected cells at 6 h and 8 h p.i.,
respectively (P = 6.48 × 10-4 and 5.23 × 10-6) (Fig. 7). To
prove that these measures were indeed HA at the cell
membrane and not cytoplasmic staining, we performed
IFAs. The IFA data indicated that the HA proteins of both
viruses were transported to the cell membrane, and in
accordance with the data from the FACS analysis, the
H3N2-infected cells showed more HA protein localizedVirology Journal 2007, 4:134 http://www.virologyj.com/content/4/1/134
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A/HK/218449/06 (H3N2) influenza virus induces greater ERK phosphorylation leading to higher virus titers Figure 2
A/HK/218449/06 (H3N2) influenza virus induces greater ERK phosphorylation leading to higher virus titers. (A) 
MDCK cells were infected with either virus at m.o.i. = 1. After Western blot analysis, ERK activation was analyzed with a mAb 
specific for the phosphorylated kinase (P-ERK). Subsequently, loading was controlled with a mAb against ERK2. Respective 
bands of three independent experiments were quantified, and relative ERK activation was calculated and normalized to the 
loading control (mock-infected, white bar). Virus types and the time of analysis post infection (p.i.) are indicated. (B) MDCK 
cells were infected with either virus at m.o.i. = 1, and the supernatant was harvested at 9 h p.i. to determine the virus titers. 
The mean virus titers are given as plaque forming units/ml. The error bars were derived from three independent experiments.Virology Journal 2007, 4:134 http://www.virologyj.com/content/4/1/134
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Higher virus-induced ERK activation leads to enhanced nuclear RNP export Figure 3
Higher virus-induced ERK activation leads to enhanced nuclear RNP export. MDCK cells were infected with H1N1 
virus or H3N2 virus at m.o.i. = 1. RNPs were stained with anti-NP mAb and Alexa488-coupled goat anti-mouse Abs (green). 
The nucleus was counterstained with TO-PRO-3 (blue). Intracellular RNP localization was analyzed at indicated time points p.i. 
by multiphoton laser scanning microscopy. The merger of both channels is shown.Virology Journal 2007, 4:134 http://www.virologyj.com/content/4/1/134
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Replication of A/HK/218847/06 (H1N1) and A/HK/218449/06 (H3N2) influenza viruses depends on ERK activation Figure 4
Replication of A/HK/218847/06 (H1N1) and A/HK/218449/06 (H3N2) influenza viruses depends on ERK activa-
tion. (A) MDCK cells were infected at m.o.i. = 1 either with H1N1 ± TPA or with H3N2 ± U0126. After Western blot analy-
sis, ERK activation was analyzed with a mAb specific for phosphorylated ERK (P-ERK). Subsequently, loading was controlled 
with a mAb against ERK2. Respective bands of three independent experiments were quantified, and relative ERK activation was 
calculated and normalized to the loading control (mock-infected, white bar). Virus types as well as the time of analysis post-
infection (p.i.) are indicated. (B) MDCK cells were infected at m.o.i. = 1 either with H1N1 ± TPA or with H3N2 ± U0126, and 
the supernatant was harvested 9 h later. The mean virus titers are given in percent as well as plaque forming units/ml. The 
error bars were derived from three independent experiments.Virology Journal 2007, 4:134 http://www.virologyj.com/content/4/1/134
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Stimulation of MAPK pathway enhances nuclear RNP export of A/HK/218847/06 (H1N1) influenza virus Figure 5
Stimulation of MAPK pathway enhances nuclear RNP export of A/HK/218847/06 (H1N1) influenza virus. 
MDCK cells were infected with H1N1 ± TPA at m.o.i. = 1. RNPs were stained with anti-NP mAb and Alexa488-coupled goat 
anti-mouse Abs (green). The nucleus was counterstained with TO-PRO-3 (blue). Intracellular RNP localization was analyzed at 
indicated time points p.i. by multiphoton laser scanning microscopy. The merger of both channels is shown.Virology Journal 2007, 4:134 http://www.virologyj.com/content/4/1/134
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Inhibition of MAPK pathway retards nuclear RNP export of A/HK/218449/06 (H3N2) influenza virus Figure 6
Inhibition of MAPK pathway retards nuclear RNP export of A/HK/218449/06 (H3N2) influenza virus. MDCK 
cells were infected with H3N2 ± U0126 at m.o.i. = 1. RNPs were stained with anti-NP mAb and Alexa488-coupled goat anti-
mouse Abs (green). The nucleus was counterstained with TO-PRO-3 (blue). Intracellular RNP localization was analyzed at indi-
cated time points p.i. by multiphoton laser scanning microscopy. The merger of both channels is shown.Virology Journal 2007, 4:134 http://www.virologyj.com/content/4/1/134
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HA surface expression of A/HK/218847/06 (H1N1) and A/HK/218449/06 (H3N2) influenza viruses Figure 7
HA surface expression of A/HK/218847/06 (H1N1) and A/HK/218449/06 (H3N2) influenza viruses. MDCK cells 
were infected with either virus at m.o.i. = 1. The percentages of HA+ cells were measured by FACS using a specific anti-HA 
mAb. In the histograms, the gray area represents the negative control; the percentage of HA+ cells at 6 h p.i. (solid lines) and 8 
h p.i. (dashed lines) are indicated. The bar graph shows the mean data from three independent experiments.Virology Journal 2007, 4:134 http://www.virologyj.com/content/4/1/134
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on the cell membrane (Fig. 8) than did the H1N1-infected
cells. IFA analysis at 6 h and 8 h p.i. showed that the level
of HA expression on the surface of H3N2-infected cells
increased, whereas that of H1N1-infected cells was con-
stant. These data clearly demonstrate that a greater
amount of the H3N2-HA accumulates on the cell mem-
brane compared with that of the H1N1-HA and suggest
that the amount of the H3N2-HA perpetually increases
during viral infection.
Viral polymerase genes PB1 and PB2 of A/HK/218449/06 
(H3N2) influenza virus exhibit higher polymerase activity 
than their counterparts in the H1N1 virus
The H3N2 virus replicated more efficiently in MDCK cells
than did the H1N1 strain, and viral polymerase genes
have been shown to contribute to virus growth and infec-
tivity [25-28]. Therefore, we analyzed the potential role of
these genes and the proteins they encode in more detail.
To investigate whether the H3N2 viral polymerase genes
possess higher activity than those of the H1N1 subtype,
we performed a luciferase assay using a minigenome sys-
tem. The pol I-driven plasmid encoding the luciferase
gene was cotransfected into the human embryonic kidney
cell line 293T HEK with pol I/pol II-responsive plasmids
that express the viral PB1, PB2, PA, and NP proteins of the
H1N1 or H3N2 virus. After 24 h, luciferase activity was
assayed in cell extracts.
To test which viral protein in the RNP complexes affect
viral polymerase activity the most, we exchanged each
plasmid encoding PB1, PB2, PA, or NP of both viruses.
Transfection without the PB1 plasmid was also assayed as
an indication for background level of non-specific luci-
ferase expression. The relative polymerase activity of the
wild type H3N2 was higher than that of the wild type
H1N1. The values obtained from the transfections com-
prising the wild type system of each virus are individually
set as 100%. Replacing H1N1 PB1 or PB2 with those genes
from the H3N2 virus significantly increased the viral
polymerase activity of the H1N1 virus by about 35% (Fig.
9A). Conversely, substitution of H3N2-PB1 or PB2 with
those genes from the H1N1 virus reduced the polymerase
activity by 91% and 70%, respectively (Fig. 9B). Replace-
ment of the polymerase genes PA and NP did not affect
the viral polymerase activity of either virus. These results
demonstrated that polymerase complex of H3N2 and
H1N1 differed substantially in their replication/transcrip-
tion activity and that the H3N2-PB1 and PB2 contributes
to higher viral polymerase activity observed between these
two viruses.
PB1 protein of A/HK/218449/06 (H3N2) influenza virus 
induces greater levels of ERK phosphorylation, which 
enhances cytoplasmic localization of the RNP complexes
The PB1 and PB2 genes appeared to have the most influ-
ence on viral polymerase activity. Since PB1 plays a central
role in the catalytic activities of the RNA-dependent RNA
polymerases [29], we focused on the PB1 gene to further
investigate whether differences in the viral polymerase
activity of H1N1 and H3N2 viruses correlate with their
ability to activate the Raf/MEK/ERK signaling. To this
point we used the eight-plasmid reverse genetics system
[30] to generate recombinant influenza viruses to assess
the potential role of the PB1 protein in virus-induced ERK
activation. Recombinant viruses rgH1N1, rgH3N2 and
rgH1N1/H3N2-PB1 were generated. The recombinant
virus with H3N2 background possessing the H1N1-PB1
gene (rgH3N2/H1N1-PB1) could not be rescued, which
might be due to gene incompatibility resulting in low res-
cue efficiency under these experimental conditions. The
rescued H1N1 virus possessing the H3N2-PB1 (rgH1N1/
H3N2-PB1) induced greater ERK phosphorylation (Fig.
10A) resulting in increased nuclear RNP export (Fig. 10B)
and higher virus titers compared with that caused by
rgH1N1 virus (Fig. 11). Only low levels of phosphor-
ylated ERK were detectable in the rgH1N1-infected cells at
6 h p.i., whereas infection with rgH3N2 or rgH1N1/
H3N2-PB1 significantly upregulated the virus-induced
ERK activation at 6 h p.i. (Fig. 10A). Analysis of intracellu-
lar RNP localization showed that substantial export of
nuclear RNP had already occurred at 6 h p.i. in cells
infected with rgH3N2 or rgH1N1/H3N2-PB1, whereas the
majority of the RNP complexes of rgH1N1-infected cells
remained in the nucleus or at the nuclear membrane at
that time point (Fig. 10B). Even though the virus titers of
rgH1N1/H3N2-PB1 was lower than that of rgH3N2 at 6 h
p.i., it was substantially higher than that of rgH1N1. These
data demonstrate that the H3N2-PB1 protein contributes
to the activation of the Raf/MEK/ERK signal cascade.
Discussion
We compared the viral replication efficiency of two strains
of IVAs isolated from two different patients in Hong Kong
in 2006. The isolated H3N2 subtype replicated more effi-
ciently than the H1N1 in MDCK cells. Interestingly,
growth capacity was related to the IVA's ability to activate
the Raf/MEK/ERK (MAPK) signal cascade. The H3N2 virus
upregulated MAPK signaling better than did the H1N1
virus. Accordingly, stimulation of MAPK signaling with
TPA, a strong kinase activator, increased the H1N1 virus
titers. In contrast, treatment of H3N2-infected cells with
the specific MEK inhibitor U0126 abolished ERK activa-
tion and severely reduced the virus titers. These data show
that replication of both viruses strongly depends on their
ability to activate the MAPK signaling. Cell treatment with
TPA or U0126 did not affect the synthesis of viral NPs atVirology Journal 2007, 4:134 http://www.virologyj.com/content/4/1/134
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HA surface expression of A/HK/218847/06 (H1N1) and A/HK/218449/06 (H3N2) influenza viruses Figure 8
HA surface expression of A/HK/218847/06 (H1N1) and A/HK/218449/06 (H3N2) influenza viruses. MDCK cells 
were infected with either virus at m.o.i. = 1. HAs were stained with anti-HA mAb and Alexa488-coupled goat anti-mouse Abs 
(green). The nuclei were counterstained with TO-PRO-3 (blue). The HA surface expression was analyzed at indicated time 
points by confocal laser scanning microscopy. The merger of both channels is shown.Virology Journal 2007, 4:134 http://www.virologyj.com/content/4/1/134
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Viral polymerase activity of A/HK/218847/06 (H1N1) and A/HK/218449/06 (H3N2) influenza viruses Figure 9
Viral polymerase activity of A/HK/218847/06 (H1N1) and A/HK/218449/06 (H3N2) influenza viruses. Polymerase 
activity was assayed in a minigenome system using a viral UTR-driven luciferase reporter gene. The 293T cells were transfected 
with plasmids containing PB2, PB1, PA, and NP genes from either H1N1 (A) or H3N2 (B) plus a luciferase reporter plasmid. 
Plasmids that did not contain PB1 were used as negative controls (white bars). After 24 h, luciferase activity was assayed in cell 
extracts. Results presented represent the means ± SE from three independent transfections.Virology Journal 2007, 4:134 http://www.virologyj.com/content/4/1/134
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The PB1 gene of the A/HK/218449/06 (H3N2) influenza virus contributes to ERK activation and enhanced nuclear RNP export Figure 10
The PB1 gene of the A/HK/218449/06 (H3N2) influenza virus contributes to ERK activation and enhanced 
nuclear RNP export. (A) MDCK cells were infected at m.o.i. = 1 with reverse genetics (rg)-rescued rgH1N1, rgH3N2, or 
rgH1N1(H3N2-PB1). After Western blot analysis, ERK activation was analyzed with a P-ERK-specific mAb. Subsequently, load-
ing was controlled with an anti-ERK2 mAb. Respective bands of three independent experiments were quantified, and relative 
ERK activation was calculated and normalized to the loading control (mock, white bar). Virus types and the time of analysis 
post infection (p.i.) are indicated. (B) MDCK cells were infected at m.o.i. = 1 with rgH1N1, rgH3N2, or rgH1N1(H3N2-PB1). 
RNPs were stained with anti-NP mAb and Alexa488-coupled goat anti-mouse Abs (green). The nucleus was counterstained 
with TO-PRO-3 (blue). Intracellular RNP localization was analyzed by confocal laser scanning microscopy at 6 h p.i. The 
merger of both channels is shown.Virology Journal 2007, 4:134 http://www.virologyj.com/content/4/1/134
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6 and 8 h p.i. (data not shown). This finding showed that
changes in virus titers, at least in part, are indeed influ-
enced by nuclear export efficiency of the RNPs.
Moreover, many studies have shown that the polymerase
genes of more replication-efficient influenza viruses play
a central role in virulence and virus replication
[25,26,31,27]. The H3N2-PB1 and PB2 significantly con-
tributed to higher polymerase activity. We further studied
the importance of the viral PB1 polymerase for virus-
induced ERK activation, because (i) replacing the PB1 pro-
tein of each virus most significantly increased or decreased
the polymerase activity and (ii) the PB1 subunit plays a
central role in the catalytic activities of the RNA polymer-
ase as it contains the conserved motifs characteristic of
RNA-dependent RNA polymerases and is directly
involved in RNA chain elongation [29]. For this purpose,
recombinant influenza viruses (rgH1N1, rgH3N2 and
rgH1N1/H3N2-PB1) were generated to assess the role of
PB1. Our data showed rgH1N1/H3N2-PB1 virus elevated
ERK phosphorylation, thereby causing enhanced export
of nuclear RNPs and increased virus titers as compared to
that of the rgH1N1 virus. However, the ERK activation
induced by rgH1N1/H3N2-PB1 is still weaker than that
induced by rgH3N2. Therefore, although the H3N2-PB1
protein appears to contribute to elevated ERK activation,
other viral proteins (e.g., HA) from wild-type H3N2 may
still be required for optimal ERK activation. On the other
hand, PB2 and particularly PB1 of H1N1 dramatically
reduced the transcription/replication activity of H3N2.
This may explain why no recombinant virus with an
H3N2 background possessing H1N1-PB1 could be res-
cued. In contrast, replacement of the H1N1-PB1 with that
of H3N2 increased the viral polymerase activity. These
findings demonstrate for the first time the relation
between viral polymerase activity and activation of MAPK
signaling. In addition to the crucial function of PB1, the
PB2 subunit is responsible for recognition and binding of
the cap structure of host mRNAs [32,33]. The role of the
PA subunit in the transcription and replication of vRNA is
less well established. However, it has been shown that the
PA subunit is required for efficient nuclear accumulation
of the PB1 protein [34]. Based on our data and this obser-
vation, it would also be interesting to further study the
possible contribution of PB2 in virus-induced MAPK acti-
vation.
Previously, we showed that a tight association of viral HA
with lipid raft domains localized in the cell membrane is
crucial for activating the virus-induced MAPK signal cas-
cade [24]. Three highly conserved cysteine residues in the
HA cytoplasmic tail of A/FPV/Rostock/34 (H7N1) at posi-
tions 551, 559, and 562 serve as acylation (palmitoyla-
tion) sites that are important for HA/lipid raft association
[35], ERK activation, nuclear RNP export, and subse-
quently infectivity [24]. Insufficient transport of HA from
the cytoplasm to the cell surface was shown to be respon-
sible for the low activation of ERK [24]. Like the H7N1-
HA, the HAs from the two IVAs examined in this study
also possess cysteine residues at these positions (Fig. 12).
On the basis of this observation, we assume that the HAs
of the H1N1 and H3N2 viruses used in this study should
therefore be able to interact with lipid raft domains to
activate the MAPK signal cascade. Unlike the H3N2 sub-
type, the H1N1 showed a severely reduced ability to acti-
vate ERK to the level required for efficient virus
replication. FACS and IFA analyses revealed that more
H3N2-HA was expressed and accumulated on the mem-
branes of infected cells than was H1N1-HA. This finding
further supports previously published data and suggests
that the difference in membrane accumulation of the
H3N2-HA compared to the H1N1-HA triggers higher acti-
vation of the MAPK cascade and more efficient nuclear
RNP export.
Next, we tried to figure out the fundamental reasons why
the H3N2 strain replicates more efficiently than the H1N1
subtype does. It is noteworthy that most of the currently
circulating H5N1 strains with pandemic potential repli-
cate very fast and exhibit high lethality in various hosts.
The viral polymerase genes, particularly PB1 and PB2,
contribute to the virulence of the human A/Vietnam/
Virus titers of recombinant influenza viruses Figure 11
Virus titers of recombinant influenza viruses. MDCK 
cells were infected with rgH1N1, rgH3N2, or 
rgH1N1(H3N2-PB1) at m.o.i. = 1, and the supernatant was 
harvested at 9 h p.i. The mean virus titers are given in per-
cent as well as plaque forming units/ml. The error bars were 
derived from three independent experiments.Virology Journal 2007, 4:134 http://www.virologyj.com/content/4/1/134
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1203/04 (H5N1) influenza virus in mice and ferrets [27].
Sequence analysis of the two IVAs examined in the current
study revealed differences in 42 amino acid (aa) residues
in the PB1 genes. Interestingly, compared with the
sequence of the PB1 of A/Vietnam/1203/04, that of
H3N2-PB1 differs by only 21 residues, while that of the
H1N1-PB1 differs by 34. Furthermore, accumulating evi-
dence indicates that from 1918 to 1947, the human H1N1
viruses contained PB1 genes with a full-length PB1-F2,
whereas beginning in 1956, human H1N1 strains contain
a PB1-F2 that is truncated after codon 57 [36]. Most of the
recent human H3N2 virus isolates encode an intact PB1-
F2 [36]. PB1-F2 protein is encoded in the +1 open-reading
frame of segment-2 RNA [10]. The C-terminal domain of
PB1-F2 contains the mitochondrial signal and can trigger
apoptosis in specific immune-related cells [36,37]. Zama-
rin et al. have demonstrated that full-length PB1-F2 con-
tributes to the virus' pathogenesis in mice [38].
Interestingly, the PB1-F2 gene of the H3N2 virus used in
this study consists of 90 aa residues (full length), whereas
that of the H1N1 consists of only 57 aa. The facts that
H3N2-PB1 has higher homology with H5N1-PB1 and
that the PB1-F2 protein of H3N2 has a full-length
sequence, may explain why the H3N2 subtype replicates
more efficiently than does the H1N1 virus and induces
higher activation levels of the MAPK signal cascade.
All together, our findings led us to conclude that the viral
polymerase complex contributes to the activation of HA-
induced MAPK signaling. Influenza virus takes advantage
of this event, in turn, to optimize viral growth. Our cur-
rent data suggest that higher viral polymerase activity
Comparison of the carboxy-terminal amino acid sequences of different HA subtypes Figure 12
Comparison of the carboxy-terminal amino acid sequences of different HA subtypes. Dashes are inserted to give 
maximum sequence homology. The conserved cysteine residues serving as acylation (palmitoylation) sites are shown in bold 
face. The HA sequences of A/HK/218847/06 (H1N1) and A/HK/218449/06 (H3N2) are highlighted in red. TMD, transmem-
brane domain; CT, cytoplasmic tailVirology Journal 2007, 4:134 http://www.virologyj.com/content/4/1/134
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enhances the replication and transcription of viral RNA,
which leads to greater expression of the viral HA protein
and its accumulation on the cell surface late during virus
replication. This in turn results in stronger ERK activation
and thereby to more efficient nuclear RNP export and for-
mation of infectious progeny virions. Understanding such
a mechanism essential for influenza virus replication may
also be a basis for the development of therapeutic impli-
cations, such as antiviral drug that reduces the polymerase
activity leading to decreased HA-membrane accumulation
and declined activation of the MAPK pathway.
Conclusion
These results showed that HK/218449/06 (H3N2) influ-
enza virus replicates more efficiently than HK/218847/06
(H1N1) subtype does. Infection with the H3N2 strain
induced higher activation levels of the Raf/MEK/ERK
(MAPK) signal cascade essential for virus replication. The
previous study demonstrated the role of HA as an inducer
of MAPK signaling causing enhanced nuclear RNP export
at late time point of infectious cycle. Applying reverse
genetic systems, we could show that the viral polymerase
proteins (particularly PB1 and PB2) of the H3N2 influ-
enza virus possess higher polymerase activity and that the
PB1 protein of the H3N2 influenza virus contributes to
the elevated HA-induced ERK activation, increased cyto-
plasmic RNP localization and higher virus titers.
Materials and methods
Cells, viruses, and infection
Human embryonic kidney cells (293T cells) were main-
tained in Dulbecco's modified Eagle's medium (DMEM)
supplemented with 10% fetal calf serum (FCS) and anti-
biotics. Madin-Darby canine kidney (MDCK) cells were
kept in minimal essential medium supplemented with
10% FCS and antibiotics. All cells were cultivated at 37°C
with 5% CO2. Human influenza viruses A/Hong Kong/
218847/06 (H1N1) and A/Hong Kong/218849/06
(H3N2) were kindly provided by Dr. Malik Peiris (Univer-
sity of Hong Kong). We rescued the following viruses by
reverse genetics (rg): rgH1N1, rgH3N2, and rgH1N1/
H3N2-PB1. These five viruses were used to infect MDCK
cells. Cells were washed with phosphate-buffered saline
(PBS), infected at the indicated multiplicity of infection
(m.o.i.), and further incubated as described previously
[23,24].
Generation of recombinant viruses by a reverse genetics 
system
H1N1 and H3N2 IVAs were propagated in MDCK cells.
RT-PCR using gene specific primers [39] was done to
amplify all eight viral genes, and viral cDNAs were
inserted into dual-promoter plasmid pHW2000 [30]. All
plasmids were sequenced, and QuikChange Site-Directed
Mutagenesis kits (Stratagene) were used to adapt the cod-
ing sequences of the cloned fragments to the sequence
identified by PCR fragment sequencing. Recombinant
viruses were generated by DNA transfection of MDCK/
293T cells as described [30]. The supernatant of trans-
fected cells was used for reinfection of MDCK cells, and
virus stock was prepared, sequenced, and titrated.
Sequence analysis
Viral RNA was isolated directly from virus-containing
supernatant by using an RNA isolation kit (RNeasy; QIA-
GEN). The universal primer set for influenza A virus was
used for RT-PCR [39]. The Hartwell Center for Bioinfor-
matics & Biotechnology at St. Jude Children's Research
Hospital determined the sequence of the DNA template
by using Big Dye Terminator (v.3) chemistry and synthetic
oligonucleotides. Samples were analyzed on 3700 DNA
analyzers (Applied Biosystems).
Plaque assay and TCID50
Confluent monolayers of MDCK cells in 35-mm dishes
were inoculated with 10-fold dilutions of influenza virus
(in DMEM with 3% BSA and antibiotics) and incubated at
37°C for 1 h. The inoculum was removed, and cells were
washed with PBS and overlaid with MEM containing 1%
agarose and 0.2% serum albumin. After 3 d at 37°C, cells
were stained with 0.1% crystal violet in 10% formalde-
hyde solution, and plaque morphology was evaluated.
Plaque size was measured using fine-scale magnifying
comparator (6×). To determine the 50% tissue culture
infecting dose (TCID50), we inoculated confluent monol-
ayers of MDCK cells in a 96-well plate with 10-fold dilu-
tions of influenza virus and incubated them at 37°C for 1
h. After inoculum removal, cells were washed with PBS
and incubated for 72 h. A 50-μl sample of supernatant was
drawn from each well, transferred to a new 96-well plate,
and virus was titrated by HA test with a 0.5% suspension
of chicken red blood cells. The TCID50 was calculated by
the method of Reed and Muench [40].
Activation and inhibition of the Raf/MEK/ERK signal 
cascade
Activation of the Raf/MEK/ERK signal cascade was
achieved by artificial stimulation of MDCK cells with 100
ng/ml 12-O-tetradecanoyl-phorbol-13-acetate (TPA)
(Sigma) at 4 h p.i.. U0126 (50 mM), a specific MEK inhib-
itor (Promega), was used to inhibit ERK activity as
described previously [23].
Detection of ERK phosphorylation by Western blotting
Cell lysate was cleared by centrifugation, and protein con-
centration was determined by Bradford assay before the
protein was subjected to SDS-PAGE. Phosphorylated ERK
(P-ERK) was detected with a specific monoclonal anti-
body (Santa Cruz Biotechnology). After stripping bound
antibodies, we detected the total ERK2 using mAbs (SantaVirology Journal 2007, 4:134 http://www.virologyj.com/content/4/1/134
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Cruz Biotechnology). Proteins recognized by mAbs were
further analyzed with peroxidase-coupled, species-specific
secondary antibodies and a standard enhanced chemilu-
minescence reaction (Amersham Biosciences). Quantifi-
cation of specific bands was done with the PC-BAS
software package (Fuji).
Confocal Laser Scanning Microscopy and 
Immunofluorescence Assay (IFA)
MDCK cells grown on glass coverslips were infected and
incubated as indicated below. The cells were washed with
PBS at the indicated time points p.i. and fixed with 4%
paraformaldehyde (PFA) in PBS at room temperature (rt)
for 30 min or at 4°C over night. Cells were permeabilized
with 1% Triton X-100 (in PBS) at rt for 10 min. Then cells
were incubated with a combination of the mouse anti-IVA
NP mAb, clone AA5H (1:100) (Abcam) in PBS/3% bovine
serum albumin (BSA) at rt for 1 h. The AlexaFluor488-
coupled goat anti-mouse antibody (Invitrogen) was used
as the secondary antibody. Cells were washed with PBS
followed by double-distilled water and mounted with P-
phenyldiamine (PPD) (Sigma) containing 500 nM TO-
PRO-3 (Molecular Probes) for nuclear staining. Fluores-
cence was visualized with a multiphoton laser scanning
microscope (Zeiss LSM 510 META). To analyze the expres-
sion of HA on the cell surface, cells were not permeabi-
lized. The HA protein in infected cells was detected by
anti-H1HA mAb (abcam, clone C102) or by anti-H3HA
(against HA of A/Mem/1/94) mAb (St. Jude Children's
Research Hospital, clone H3/94/49) and AlexaFluor488-
coupled goat anti-mouse antibody as secondary antibody.
Flow cytometry (FACS) analysis
MDCK cells were infected with either HK/218847 (H1N1)
or HK/218449 (H3N2) as indicated below. Cells were
incubated for 4, 6, or 8 h. Then the cells were detached
with trypsin, fixed in PBS/4% PFA, permeabilized with
1% Triton X-100, and stepwise incubated with FITC-con-
jugated mouse anti-NP mAb, (clone IA52, 1:500; Argene
INC) in PBS/3% BSA for 30 min on ice. Finally, the per-
centage of NP-expressing cells was determined by flow
cytometry analysis using FACSCalibur (BD Biosciences).
To analyze expression of HA on the cell surface, cells were
not permeabilized. The HA protein in infected cells was
detected by anti-H1HA mAb (abcam, clone C102) or by
anti-H3HA mAb (St. Jude Children's Hospital, clone H3/
94/49) and AlexaFluor488-coupled goat anti-mouse anti-
body as secondary antibody.
Luciferase assays
Subconfluent monolayers of 293T cells (7.5 × 105 cells in
35-mm dishes) were transfected (Mirus Bio) with 2 μg
luciferase reporter plasmid (EGFP open-reading frame in
pHW72-EGFP substituted with luciferase gene [30] and a
mix of PB2 (1 μg), PB1 (1 μg), PA (1 μg), and NP (2 μg)
plasmids of A/HK/218847/06 (H1N1) and A/HK/
218449/06 (H3N2) viruses. After 24 h, cell extracts were
prepared in 500 μl lysis buffer, and luciferase levels were
assayed with a Luciferase Assay System (Promega) and BD
Monolight 3010 luminometer (BD Biosciences). Experi-
ments were performed in triplicate.
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